Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion type Assertion NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_head.
- NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion description "[Up till now EGFR gene mutations, KRAS gene mutations and EML4-ALK fusion genes are the most widely recognized alterations involved in both the biology and the clinical management of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_provenance.
- NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion evidence source_evidence_literature NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_provenance.
- NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion SIO_000772 21129606 NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_provenance.
- NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion wasDerivedFrom befree-2016 NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_provenance.
- NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_assertion wasGeneratedBy ECO_0000203 NP856822.RAEKa6N3vZ8ZgmOAxKLGc0Rhm1Xx2Qaq-EOVr52NlLw3E130_provenance.